The B subunits of Shiga-like toxins induce regulated VWF secretion in a phospholipase D1-dependent manner

被引:13
作者
Huang, Jing [1 ,2 ,3 ]
Haberichter, Sandra L. [4 ,5 ]
Sadler, J. Evan [1 ,2 ,3 ]
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Biochem, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Mol Biophys, St Louis, MO 63110 USA
[4] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA
[5] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
基金
美国国家卫生研究院;
关键词
VON-WILLEBRAND-FACTOR; HEMOLYTIC-UREMIC SYNDROME; HUMAN ENDOTHELIAL-CELLS; WEIBEL-PALADE BODIES; ESCHERICHIA-COLI; D1; EXOCYTOSIS; CYTOSKELETON; TRANSPORT; PROTEINS;
D O I
10.1182/blood-2012-01-408096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Shiga toxin (Stx) causes diarrhea-associated hemolytic uremic syndrome by damaging renal microvascular endothelium. The pentameric B subunits of Stx types 1 and 2 (Stx1B and Stx2B) are sufficient to stimulate acute VWF secretion from endothelial cells, but Stx1B and Stx2B exert distinct effects on Ca2+ and cAMP pathways. Therefore, we investigated other signaling components in StxB-induced VWF exocytosis. Incubation of HUVECs with StxB transiently increased phospholipase D (PLD) activity. Inhibition of PLD activity or shRNA-mediated PLD1 knockdown abolished StxB-induced VWF secretion. In addition, treatment with StxB triggered actin polymerization, enhanced endothelial monolayer permeability, and activated RhoA. PLD activation and VWF secretion induced by Stx1B were abolished on protein kinase C alpha (PKC alpha) inhibition or gene silencing but were only moderately reduced by Rho or Rho kinase inhibitors. Conversely, PLD activation and VWF exocytosis induced by Stx2B were reduced by Rho/Rho kinase inhibitors and dominant-negative RhoA, whereas attenuation of PKC alpha did not affect either process. Another PLD1 activator, ADP-ribosylation factor 6, was involved in VWF secretion induced by Stx1B or Stx2B, but not histamine. These data indicate that Stx1B and Stx2B induce acute VWF secretion in a PLD1-dependent manner but do so by differentially modulating PKC alpha, RhoA, and ADP-ribosylation factor 6. (Blood. 2012;120(5):1143-1149)
引用
收藏
页码:1143 / 1149
页数:7
相关论文
共 31 条
[1]   A phosphatidylinositol-3-kinase-dependent signal transition regulates ARF1 and ARF6 during Fcγ receptor-mediated phagocytosis [J].
Beemiller, Peter ;
Hoppe, Adam D. ;
Swanson, Joel A. .
PLOS BIOLOGY, 2006, 4 (06) :987-999
[2]   ARF6 Regulates the Synthesis of Fusogenic Lipids for Calcium-regulated Exocytosis in Neuroendocrine Cells [J].
Begle, Aurelie ;
Tryoen-Toth, Petra ;
de Barry, Jean ;
Bader, Marie-France ;
Vitale, Nicolas .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (08) :4836-4845
[3]   Phospholipase D1 is specifically required for regulated secretion of von Willebrand factor from endothelial cells [J].
Disse, Jennifer ;
Vitale, Nicolas ;
Bader, Marie-France ;
Gerke, Volker .
BLOOD, 2009, 113 (04) :973-980
[4]   Phospholipase D: Enzymology, mechanisms of regulation, and function [J].
Exton, JH .
PHYSIOLOGICAL REVIEWS, 1997, 77 (02) :303-320
[5]   Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7 [J].
Fraser, ME ;
Fujinaga, M ;
Cherney, MM ;
Melton-Celsa, AR ;
Twiddy, EM ;
O'Brien, AD ;
James, MNG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) :27511-27517
[6]   Mammalian phospholipase D structure and regulation [J].
Frohman, MA ;
Sung, TC ;
Morris, AJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1439 (02) :175-186
[7]   Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) [J].
Haberichter, Sandra L. ;
Castarnan, Giancarlo ;
Budde, Ulrich ;
Peake, Ian ;
Goodeve, Anne ;
Rodeghiero, Francesco ;
Federici, Augusto B. ;
Batlle, Javier ;
Meyer, Dominique ;
Mazurier, Claudine ;
Goudemand, Jenny ;
Eikenboom, Jeroen ;
Schneppenheim, Reinhard ;
Ingerslev, Jorgen ;
Vorlova, Zdena ;
Habart, David ;
Holmberg, Lars ;
Lethagen, Stefan ;
Pasi, John ;
Hill, Frank G. H. ;
Montgomery, Robert R. .
BLOOD, 2008, 111 (10) :4979-4985
[8]   Characterization of two alternately spliced forms of phospholipase D1 - Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and RHO family monomeric GTP-binding proteins and protein kinase C-alpha [J].
Hammond, SM ;
Jenco, JM ;
Nakashima, S ;
Cadwallader, K ;
Gu, QM ;
Cook, S ;
Nozawa, Y ;
Prestwich, GD ;
Frohman, MA ;
Morris, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3860-3868
[9]   Differential kinetics of cell surface loss of von Willebrand factor and its propolypeptide after secretion from Weibel-Palade bodies in living human endothelial cells [J].
Hannah, MJ ;
Skehel, P ;
Erent, M ;
Knipe, L ;
Ogden, D ;
Carter, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (24) :22827-22830
[10]   Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice [J].
Huang, Jing ;
Motto, David G. ;
Bundle, David R. ;
Sadler, J. Evan .
BLOOD, 2010, 116 (18) :3653-3659